Search clinical trials for: CC-5013 (lenalidomide)
Total 1922 results
-
Tactile MedicalCompletedBreast Cancer LymphedemaUnited States
-
Tactile MedicalTerminatedHead and Neck LymphedemaUnited States
-
Philip Morris Products S.A.Completed
-
BeBetter Med IncCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterSyndax PharmaceuticalsNot yet recruitingLeukemia | HOX GeneUnited States
-
Syndax PharmaceuticalsAvailable
-
Grupo Español de Linfomas y Transplante Autólogo...Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, IncCompleted
-
Celgene CorporationICON Clinical ResearchCompletedMyelodysplastic SyndromesGermany, Israel, United Kingdom, Spain, Belgium, Italy, France, Netherlands, Sweden
-
University Hospital TuebingenRecruitingProstate Cancer RecurrentGermany
-
University Hospital TuebingenGerman Cancer Research CenterRecruitingCastration-Resistant Prostatic CancerGermany
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
Bristol-Myers SquibbCompletedHealthy ParticipantsChina
-
The University of Texas Health Science Center,...National Heart, Lung, and Blood Institute (NHLBI); Memorial Hermann HospitalCompletedExposure to Secondhand Smoke in Neonatal InfantsUnited States
-
Hutchison Medipharma LimitedCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Novo Nordisk A/SRecruiting
-
GenmabAbbVieRecruitingNon-hodgkin LymphomaUnited States, Australia, France, Israel, Korea, Republic of, Spain, Taiwan, Japan, Italy, Belgium, Germany, Canada, Turkey, Czechia
-
M.D. Anderson Cancer CenterCompletedSolid TumorsUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenzaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Bellicum PharmaceuticalsActive, not recruitingLymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous LeukemiaUnited States
-
CelgeneTerminatedLymphoma, Large B-Cell, DiffuseUnited States, France, Canada, Italy
-
Syndax PharmaceuticalsRecruitingColorectal Cancer | Solid TumorsUnited States
-
Hutchison Medipharma LimitedSun Yat-sen University; Fudan UniversityCompleted
-
Hutchison Medipharma LimitedFudan University; Eighty-One Hospital of People's Liberation ArmyCompleted
-
Hutchison Medipharma LimitedShanghai Chest HospitalCompletedNon-small Cell Lung CancerChina
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Yale UniversityAmerican Foundation for Suicide PreventionRecruitingMood Disorders | Bipolar Disorder | Suicidal Ideation | Suicide | Major Depressive DisorderUnited States
-
CelgeneCompletedLymphoma | Lymphoma, Large B-Cell, Diffuse | Glioblastoma | Multiple Myeloma | Primary Central Nervous System Lymphoma | Pleiotropic Pathway ModifierUnited States, Spain, Belgium, France, Italy
-
Cocrystal Pharma, Inc.Completed
-
AutotelicbioRecruitingDiabetes Mellitus, Type 2 | Essential HypertensionKorea, Republic of
-
GenmabAbbVieRecruitingDiffuse Large B-Cell Lymphoma | Classic Follicular LymphomaUnited States, Puerto Rico
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
German Cancer Research CenterRecruitingColorectal CancerGermany
-
CelgeneCompleted
-
German Cancer Research CenterUniversity Hospital TuebingenTerminatedLung Cancer Squamous CellGermany
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Philip Morris Products S.A.CompletedSmokingUnited Kingdom
-
CelgeneCompletedSafety and Pharmacokinetics in Healthy Volunteer SubjectsUnited States
-
International Medical UniversityCompleted
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Boston VA Research Institute, Inc.Celgene Corporation; Edward Hines Jr. VA Hospital; Michael E. DeBakey VA Medical... and other collaboratorsCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
CelgeneRecruitingEosinophilic EsophagitisUnited States, Belgium, Australia, Canada, Italy, Austria, Germany, Israel, Japan, Poland, Portugal, Spain, United Kingdom, Argentina, Switzerland
-
CelgeneCompletedHealthy VolunteersUnited States